Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 6/20 | 0.42 |
| ▸ | CES2 | O00748 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | GAPDH | P04406 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.32 |
| ▸ | PPARG | P37231 | 2/20 | 0.32 |
| ▸ | PPARD | Q03181 | 2/20 | 0.32 |
| ▸ | PPARA | Q07869 | 2/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL309929 | 1.00 | CES1 (0.42) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL1782116 | 0.93 | CES2 (0.44) | CES1CES2ALDH1A1TSHRTRPA1 | |
| SCHEMBL1782114 | 0.93 | CES2 (0.44) | CES1CES2ALDH1A1TSHRTRPA1 | |
| SCHEMBL1784342 | 0.91 | CES2 (0.46) | CES1CES2ALDH1A1TSHRGPR84 | |
| SCHEMBL1784339 | 0.91 | CES2 (0.46) | CES1CES2ALDH1A1TSHRGPR84 | |
| SCHEMBL1785867 | 0.84 | — | — | |
| SCHEMBL1785866 | 0.84 | — | — | |
| SCHEMBL8400960 | 0.75 | CES1 (0.37) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL2533712 | 0.75 | CES1 (0.37) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL8400962 | 0.75 | CES1 (0.37) | CES1CES2ALDH1A1TP53CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111050856-B | Methods for identifying positive allosteric modulators of odorant receptors | 弗门尼舍有限公司 | 2024-12-31 | — | — | CN | claimed |
| US-12558306-B2 | Cosmetic compositions and methods of their use | MARY KAY INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250332079-A1 | TOPICAL SUNSCREEN | CONCEPT MATRIX SOLUTIONS | 2025-10-30 | — | — | US | disclosed |
| US-12350356-B2 | Topical sunscreen | CONCEPT MATRIX SOLUTIONS | 2025-07-08 | — | — | US | disclosed |
| US-20240238193-A1 | COSMETIC COMPOSITIONS AND METHODS OF THEIR USE | MARY KAY INC. | 2024-07-18 | — | — | US | disclosed |
| EP-3697370-B1 | HAIR COLORING COMPOSITION COMPRISING MICROCAPSULES | FIRMENICH & CIE (CH) | 2024-06-12 | — | — | EP | disclosed |
| US-11969498-B2 | Cosmetic compositions and methods of their use | MARY KAY INC. (US) | 2024-04-30 | — | — | US | disclosed |
| CN-111417373-B | Hair dyeing composition comprising microcapsules | 弗门尼舍有限公司 | 2024-04-12 | — | — | CN | disclosed |
| EP-3765088-B1 | TRANSDERMAL AND/OR DERMAL DELIVERY OF LIPOPHILIC ACTIVE AGENTS | POVIVA CORP (US) | 2024-03-20 | — | — | EP | disclosed |
| US-11484480-B2 | Hair coloring composition comprising microcapsules | FIRMENICH SA (CH) | 2022-11-01 | — | — | US | disclosed |
| WO-2007028478-A1 | PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCED PROPERTIES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007028480-A1 | PARTICLES CONTAINING ZEOLITE AND PERFUME HAVING IMPROVED FRAGRANCE PROPERTIES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007028479-A1 | CONSUMER PRODUCTS HAVING VARYING ODORS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007028477-A1 | CONSUMER PRODUCTS HAVING VARYING ODOR PATTERNS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-03-15 | — | — | WO | disclosed |
| EP-1361921-A1 | SHAPED COPPER AND CHROMIUM CONTAINING CATALYST FOR USE IN HYDROGENATION AND DEHYDROGENATION REACTIONS | Degussa AG (DE) | 2003-11-19 | — | — | EP | disclosed |
| WO-2002068119-A1 | SHAPED COPPER AND CHROMIUM CONTAINING CATALYST FOR USE IN HYDROGENATION AND DEHYDROGENATION REACTIONS | DEGUSSA AG (DE) | 2002-09-06 | — | — | WO | disclosed |
| WO-1998002406-A1 | RECYCLE AND RECOVERY OF USEFUL PRODUCTS FROM HEAVY ALDOL BY-PRODUCTS | EXXON CHEMICAL PATENTS, INC. (US) | 1998-01-22 | — | — | WO | disclosed |
| EP-0804402-A1 | ORGANIC COMPOUNDS AND PROCESSES FOR THEIR MANUFACTURE | EXXON CHEMICAL PATENTS INC. (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996022268-A1 | ORGANIC COMPOUNDS AND PROCESSES FOR THEIR MANUFACTURE | EXXON CHEMICAL PATENTS INC. (US) | 1996-07-25 | — | — | WO | disclosed |
| US-4270006-A | CONCURRENT HYDROGENATION AND ALDOL CONDENSATION OF AN ALKYL ALDEHYDE OR KETONE USING A CATALYST SYSTEM COMPRISING A GROUP 8 METAL AND A RARE EARTH OXIDE OR SALT | BASF AKTIENGESELLSCHAFT (DE) | 1981-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332079-A1 | TOPICAL SUNSCREEN | SUN2, CYP51A1, DSG1 | CES1 599/4885CES2 1019/4885ALDH1A1 1641/4885 |
| US-11969498-B2 | Cosmetic compositions and methods of their use | TYR, H1-5, ADH4 | CES1 2511/4885CES2 2446/4885ALDH1A1 322/4885 |
| US-12558306-B2 | Cosmetic compositions and methods of their use | CUTA, GLA, ADH7 | CES1 2638/4885CES2 1987/4885ALDH1A1 704/4885 |
| US-12350356-B2 | Topical sunscreen | SUN2, CYP51A1, DSG1 | CES1 599/4885CES2 1019/4885ALDH1A1 1641/4885 |
| US-20240238193-A1 | COSMETIC COMPOSITIONS AND METHODS OF THEIR USE | CUTA, GLA, GPX4 | CES1 2294/4885CES2 1467/4885ALDH1A1 1043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.